French National Observatory of the Patients With Non-small Cell Lung (NSCLC) and Molecular Testings
French National Observatory of the Patients With Non-small Cell Lung (NSCLC) Benefiting From a Molecular Test on the Hospital Platforms of Molecular Genetics.
Sponsor: Intergroupe Francophone de Cancerologie Thoracique
Listed as NCT01700582, this observational or N/A phase trial focuses on ALK Gene Mutation and BRAF Gene Mutation and remains completed. Sponsored by Intergroupe Francophone de Cancerologie Thoracique, it has been updated 9 times since 2012, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Aug 2023 — Jul 2024 [monthly]
Completed
-
Jul 2022 — Aug 2023 [monthly]
Completed
▶ Show 4 earlier versions
-
Jan 2021 — Jul 2022 [monthly]
Completed
-
Jun 2018 — Jan 2021 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
Apr 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Intergroupe Francophone de Cancerologie Thoracique
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Agen, France , Albi, France , Amiens, France , Angers, France , Antony, France , Aulnay-sous-Bois, France , Auxerre, France , Avignon, France , Bayonne, France , Besançon, France and 94 more locations